AbbVie Inc. (ABBV)
NYSE: ABBV
· Real-Time Price · USD
209.53
3.34 (1.62%)
At close: Aug 20, 2025, 1:27 PM
ABBV Gamma Exposure By Expiry
The total Gamma Exposure (GEX) for ABBV across all expirations is 326,474.83 shares per 1% move, with 487,933.51 from calls and 161,458.68 from puts. The put-call GEX ratio of 0.33 shows call-heavy positioning, potentially creating volatility as market makers hedge by selling into strength and buying weakness. The highest gamma concentration is at the Sep 19, 25 expiration with 102,595.2 net GEX, which may act as a magnet point for price action. Near-term exposure for Aug 22, 25 suggests potential support from positive gamma hedging flows.
ABBV GEX Table
| Expiry Date | Call GEX | Put GEX | Net GEX | P/C GEX |
|---|---|---|---|---|
| Aug 22, 25 | 40,433.24 | -16,077 | 24,356.24 | 0.40 |
| Aug 29, 25 | 33,350.71 | -3,864.8 | 29,485.91 | 0.12 |
| Sep 5, 25 | 5,009.32 | -826.4 | 4,182.92 | 0.16 |
| Sep 12, 25 | 4,664.53 | -1,996.75 | 2,667.78 | 0.43 |
| Sep 19, 25 | 138,279.11 | -35,683.91 | 102,595.2 | 0.26 |
| Sep 26, 25 | 6,226.29 | -839.74 | 5,386.55 | 0.13 |
| Oct 17, 25 | 36,118.56 | -6,924.22 | 29,194.34 | 0.19 |
| Nov 21, 25 | 56,761.99 | -20,178.75 | 36,583.24 | 0.36 |
| Dec 19, 25 | 34,590.26 | -14,010.19 | 20,580.07 | 0.41 |
| Jan 16, 26 | 97,112.93 | -34,689.18 | 62,423.75 | 0.36 |
| Feb 20, 26 | 3,519.81 | -3,232.3 | 287.51 | 0.92 |
| Mar 20, 26 | 6,823.62 | -5,943.37 | 880.25 | 0.87 |
| Jun 18, 26 | 11,954.72 | -10,441.57 | 1,513.15 | 0.87 |
| Sep 18, 26 | 1,709.73 | -1,654.18 | 55.55 | 0.97 |
| Jan 15, 27 | 11,378.69 | -5,096.32 | 6,282.37 | 0.45 |